ArticlePreventing chronic disease2016
How Medicaid and Other Public Policies Affect Use of Tobacco Cessation Therapy, United States, 2010-2014.
Article in Preventing chronic disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment.Tobacco control · 2020Trial
- Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2019Trial
- Exploring the capacity of smoking cessation services in the Philippines.Tobacco prevention & cessation · 2026Article
- Regional and social disparities in cessation behavior and motivation to quit among U.S. adult current smokers, Tobacco Use Supplement to the U.S. Census Bureau's Current Population Survey 2014-15 and 2018-19.Frontiers in public health · 2024Article
- A Financial Incentives Program to Promote Smoking Cessation Among Recently Hospitalized Individuals: Feasibility and Acceptability Study.JMIR formative research · 2023Article
- Prescription Smoking-Cessation Medication Fills and Spending, 2009-2019.American journal of preventive medicine · 2022Article
- Medicaid coverage for tobacco dependence treatment: Enrollee awareness and use.Preventive medicine reports · 2021Article
- Public insurance expansions and smoking cessation medications.Economic inquiry · 2019Article
- Smoking Cessation among Female and Male Veterans before and after a Randomized Trial of Proactive Outreach.Women's health issues : official publication of the Jacobs Institute of Women's Health · 2019Article
- How does reimbursement status affect smoking cessation interventions? A real-life experience from the Eastern Black Sea region of Turkey.Tobacco induced diseases · 2019Article
- Addressing Tobacco Cessation at Federally Qualified Health Centers: Current Practices & Resources.Journal of health care for the poor and underserved · 2019Article
- State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2015-2017.MMWR. Morbidity and mortality weekly report · 2018Article
- Crossing Boundaries.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionState Medicaid programs can cover tobacco cessation therapies for millions of low-income smokers in the United States, but use of this benefit is low and varies widely by state. This article assesses the effects of changes in Medicaid benefit policies, general tobacco policies, smoking norms, and public health programs on the use of cessation therapy among Medicaid smokers.
methodsWe used longitudinal panel analysis, using 2-way fixed effects models, to examine the effects of changes in state policies and characteristics on state-level use of Medicaid tobacco cessation medications from 2010 through 2014.
resultsMedicaid policies that require patients to obtain counseling to get medications reduced the use of cessation medications by approximately one-quarter to one-third; states that cover all types of cessation medications increased usage by approximately one-quarter to one-third. Non-Medicaid policies did not have significant effects on use levels.
conclusionsStates could increase efforts to quit by developing more comprehensive coverage and reducing barriers to coverage. Reductions in barriers could bolster smoking cessation rates, and the costs would be small compared with the costs of treating smoking-related diseases. Innovative initiatives to help smokers quit could improve health and reduce health care costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.